TRIP6 and colorectal carcinoma: To gain deeper insight into whether the TRIP6 high and low expression groups display significant disparities in terms of the tumor immune microenvironment in CRC, we conducted a comprehensive evaluation of the differentiated expression of 24 variants of immune cells.